Back to Results
First PageMeta Content
Pharmacology / Design of experiments / Evaluation methods / Research / Bioethics / Clinical trial / Placebo / Repeated measures design / Fluticasone furoate / Science / Scientific method / Clinical research


22-051S008 Fluticasone Statistical PREA
Add to Reading List

Open Document

File Size: 211,14 KB

Share Result on Facebook

City

Reference / /

Company

GlaxoSmithKline / /

Country

France / United States / Canada / Argentina / Chile / Peru / /

Currency

pence / /

Event

FDA Phase / /

IndustryTerm

to-be-marketed delivery device / axis protocol / parallel / e-diaries / /

MedicalCondition

perennial allergic rhinitis / lens opacities / Allergy / seasonal and perennial allergic rhinitis / /

Organization

U.S. Department of Health and Human Services / office of Biostatistics Statistical Reviewer / Division of Pulmonary / FDA / Food and Drug Administration Center for Drug Evaluation / Translational Science Office / Research Office / /

Person

Badrul A Chowdhury / Robert Abugov / Thomas Permutt / Joan Buenconsejo / Concurring Reviewer / Carol Hill / Team / Susan Limb / /

Position

Investigator / Project Manager / Statistics Supervisor / Director Division / Director Medical Division / /

Product

prednisone / Veramyst / Drug Development Veramyst® Nasal Spray / Veramyst® Nasal Spray / FFR101782 / FFR20002 / FFR102123 / FFR100012 / /

Technology

pediatric HPA axis protocol / Followup Protocol Deviation Protocol / Drug Development / /

SocialTag